Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use
NCT05163119 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200
Last updated 2025-06-19
Summary
The purpose of this study is to conduct a randomized controlled trial to determine the effects of a cellphone app and a driving mode intervention on driving behavior in drivers aged 18-24 years.
Conditions
- Cell Phone Use
- Automobile Driving
Interventions
- BEHAVIORAL
-
Commercial Cellphone-Blocking App (Active)
The Fleetsafer app, which is a commercial cellphone app that uses a cellphone's standard sensors and function to block handheld cellphone use while driving, will be downloaded on the participant's smartphone.
- BEHAVIORAL
-
Driving Mode
Apple's "Do Not Disturb" driving mode provided by Apple for iPhones or Google Do Not Disturb, Verizon Messages +, Android Auto or have another app, called LifeSaver installed on their Android phone (collectively referred to as driving modes; the specific driving mode for participants in this arm will be determined based on smartphone type and service provider).
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
Ohio State University
collaborator OTHER -
University of Iowa
collaborator OTHER -
Motao Zhu
lead OTHER
Principal Investigators
-
Motao Zhu · Abigail Wexner Research Institute at Nationwide Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-09
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
NCT00458445 ·Status: WITHDRAWN ·Phase: PHASE3
-
Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT04027361 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
NCT00536419 ·Status: UNKNOWN ·Phase: PHASE4
-
Enhancing ADHD Driving Performance With Stimulant Medication
NCT00572026 ·Status: UNKNOWN ·Phase: NA
-
The Effectiveness of Cognitive-Functional Intervention to Reduce Driving Risk Factors of Adolescents With ADHD
NCT05832957 ·Status: COMPLETED ·Phase: NA
-
Improving ADHD Teen Driving - Virtual Reality
NCT06960980 ·Status: RECRUITING ·Phase: NA
-
Reducing Smartphone Overuse for Adolescents With Attention-Deficit Hyperactive Disorder
NCT07092787 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
NCT00223561 ·Status: COMPLETED ·Phase: PHASE4
-
Inhibition Control of Children and Adolescents With ADHD
NCT01677819 ·Status: COMPLETED
-
Training Attentional Awareness and Control in ADHD
NCT02489279 ·Status: COMPLETED ·Phase: NA
-
Time Perception Deficits and Attention-Deficit/Hyperactivity Disorder
NCT00491647 ·Status: COMPLETED
-
Development of a Mobile App for an Executive Functioning Intervention for Adolescents
NCT04018794 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
NCT00214981 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
NCT01081132 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
NCT02555150 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Behavioral Parent Training for Childhood ADHD: A Micro-randomized Trial
NCT06012851 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Mobile Neurofeedback for ADHD Youth
NCT04469335 ·Status: UNKNOWN ·Phase: NA
-
Stimulant Effects on Brain Activity
NCT02453698 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01274221 ·Status: WITHDRAWN ·Phase: PHASE3
-
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01069523 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
NCT00151970 ·Status: COMPLETED ·Phase: PHASE2
-
Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
NCT05048186 ·Status: COMPLETED
-
Digital Media Usage With Impulsivity and Attention Deficit in Children
NCT05428085 ·Status: COMPLETED
-
Development, Attention, and Inhibition Study
NCT06605001 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).
NCT02141113 ·Status: COMPLETED ·Phase: PHASE4